Signalife launched the sales of its new, FDA-approved, ambulatory 12-lead ECG cardiovascular monitor, the Fidelity 100.
The Fidelity 100 is a patient module that wirelessly transmits the ECG to a data collection device (laptop), which reportedly can store up to 2500 hours of data. During patient evaluation, a physician can mark events of interest. After the ECG procedure, marked events can be quickly evaluated and data can be stored to flash memory for future evaluation, said the company.
November 21, 2023 β AccurKardia, an ECG-led diagnostics software company, announced a multi-year agreement with Lucem ...
November 21, 2023 
October 13, 2023 β InfoBionic, Inc. today announced that it received 510(k) clearance from the U.S. Food and Drug ...
October 13, 2023 
October 13, 2023 β The newly MDR-certified Cardiomatics solution is accurate, fast and easy-to-use AI-based standalone ...
October 13, 2023 
September 26, 2023 β Heart Test Laboratories, Inc., an AI-powered medical technology company focused on transforming ...
September 26, 2023 
September 6, 2023 β Vektor Medical, developer of the only technology to accurately map arrhythmias using just 12-lead ...
September 06, 2023 
August 15, 2023 β Clario, a healthcare research technology company that delivers leading endpoint technology solutions ...
August 15, 2023 
July 27, 2023 β Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-based medical ...
July 27, 2023 
June 21, 2023 β Anumana, Inc., a leading AI-driven health technology company, has received Breakthrough Device ...
June 21, 2023 
June 19, 2023 β AliveCor, a global leader in personal electrocardiogram (ECG) technology, has announced a groundbreaking ...
June 19, 2023 
June 9, 2023 β Mount Sinai researchers have developed an innovative artificial intelligence (AI) model for ...
June 09, 2023